Fun with Balls/Lymb.io: The Corona Crisis Factor in Valua­tion #DHDL

The anti-​Corona measures have also often hit start-​ups espe­cially hard. Those that were able to survive the months-​long closures of entire sectors by adap­ting quickly then often needed the next round of finan­cing sooner than planned. But most of them are worse off at that point. So how does one deal with such a collapse in turnover through no fault of one's own when it comes to valua­tion?

Mittwoch,
06.10.2021

Fun with Balls, now Lymb.io, was abso­lutely trans­pa­rent with its own situa­tion when they came to “Die Höhle der Löwen”. The system, which makes it possible to combine computer games with real sports and thus wants to finally get even the laziest off the couch, used to address mainly estab­lish­ments like hotels and gyms because of its size and a price star­ting at €5,000. But it was precisely these that were hit hardest by the pan-​dem measures. After a strong start in 2019, the startup expe­ri­enced an almost unima­gi­nable slump in demand. From a turnover of 1.4 million euros, it went down to 810,000 euros, even though at the end of 2019 ever­y­thing was poin­ting to strong growth.

Now they came into “the cave” and wanted 1.6 million euros – at a valua­tion of a whop­ping 16 million. It was clear that this made the lions swallow at first. And it was also clear that the valua­tion would defi­ni­tely become a topic of discus­sion.

And the foun­ders also brought their latest product with them: Lymb.io is prac­ti­cally the variant for the home, a kind of game console that, combined with a projector, enables a similar gaming expe­ri­ence on any free wall. From now on, it is prima­rily private custo­mers who are to be addressed until the original busi­ness segment is up and running again.

Many viewers will now have prepared them­selves for a tough valua­tion discus­sion – because if you take the pre-​Corona turnover, you still end up with a good 10-fold multiple in the proposed valua­tion. But since the foun­ders only offered 10% of their shares in the initial offer, an investor could easily halve or triple the valua­tion in a counter-​offer. And the foun­ders could counter with various argu­ments. Previous invest­ments with avoidance of a down­round, current sales pipe­lines and larger distri­bu­tion part­nerships could certainly play a role here.

But this does not seem to play a role, at least the viewer learns nothing about this. Because although all the lions praise the system itself and Judith Williams in parti­cular seemed very enthu­si­a­stic about her test, the rating seems so high that it doesn’t even come to a nego­tia­tion. Carsten Masch­meyer calls the company a „Corona loser“, which the foun­ders don’t even contra­dict. He also says that their valua­tion is that of Corona winners. Of course, this can be inter­preted to mean that Corona winners are those whose busi­ness has not been greatly affected by the measures. Because as we saw in the Porthy case, for example, inves­tors often don’t like it when a start-​up jumps comple­tely on the pandemic band­wagon. Because here you have to reckon with sales plum­me­ting as soon as the situa­tion changes again.

But „normal“ conti­nued to be the case for almost no start-​up. Many in the field of e-​commerce and deli­very services saw enor­mous growth, but this cannot last. Others saw a signi­fi­cant decline in turnover. For those who were able to reorient them­selves in time, it was ulti­ma­tely just a bend. But how does one then evaluate this kink? It would not be fair to include only the new busi­ness model in the evalua­tion, as long as the old one still exists and can pick up speed again at any time. Most start-​ups would be very happy if the effects of the Corona measures were simply „factored out“, i.e. if the curve were prac­ti­cally conti­nued and the valua­tion applied that would probably have been reached under normal circums­tances at the current time. But it is not only in „Die Höhle der Löwen“ that inves­tors are very rarely prepared to do this. And who could blame them, after all, no one can say when and if things will return to „normal“, or whether some sectors of the economy will not have changed perma­nently. Or even consumer beha­viour.

Of course, that’s not fair some­where; after all, this is a situa­tion that could not have been prevented by any start-​up in the world. And so one could also compare it to other sales slumps that are comple­tely not one’s fault and that can only be predicted poorly or not at all. But here, too, inves­tors are rarely willing to comple­tely ignore the kink in turnover. Most, however, settle some­where in the middle between the actual and the would-​be situa­tion. The less recom­men­dable ones, however, take advan­tage of the resul­ting finan­cial pres­sure on the start-​ups to further depress the valua­tion.

Of course, this has never been observed with the lions, and the valua­tion of Lymb.io could also be under­stood more on the basis of the conti­nued revenue deve­lo­p­ment, which looked very strong espe­cially at the end of 2019. Unfor­tu­na­tely, we don’t learn anything more about the exact calcu­la­tion, but only see the lions exit with the valua­tion justi­fi­ca­tion.

Lymb.io has now even comple­tely replaced „Fun with Balls“ as the company name and the home systems are already available for pre-​order. So let’s keep our fingers crossed that they will end up being one of the start-​ups that only had a bump in growth and a successful tran­si­tion. And that they will thus be able to pursue their mission of finally helping people to move more again for a long time to come.

Photo (above): TVNOW / Bernd-​Michael Maurer

Ruth Cremer

Ruth Cremer ist Mathe­ma­ti­kerin und Bera­terin sowie Hoch­schul­do­zentin auf dem Gebiet der Geschäfts­mo­delle, Kenn­zahlen und Finanz­pla­nung. Als ehema­lige Invest­ment­ma­na­gerin weiß sie, worauf Inves­toren achten und hilft auch bei der Pitch-​ und Doku­men­ten­er­stel­lung im Investitions-​ oder Über­nah­me­pro­zess. Seit 2017 ist sie als externe Bera­terin an der Auswahl und Vorbe­rei­tung der Kandi­daten in "Die Höhle der Löwen" betei­ligt.